Dr. Moazzam Habib, MD (he/him) is an Endocrinologist in Indianapolis, IN with over 16 years of experience. What is your opinion of Dr. Moazzam Habib, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Moazzam Habib, MD has received over $72,322 which includes payments from the following companies:
$54,862.85 from LILLY USA, LLC
$2,392.18 from Novo Nordisk Inc
$2,229.13 from AstraZeneca Pharmaceuticals LP
$1,521.07 from sanofi-aventis U.S. LLC
$1,018.60 from Janssen Pharmaceuticals, Inc
$936.92 from Amgen Inc.
$870.65 from Corcept Therapeutics
$823.20 from Endo Pharmaceuticals Inc.
$689.09 from Boehringer Ingelheim Pharmaceuticals, Inc.
$569.75 from MannKind Corporation
$553.33 from Merck Sharp & Dohme Corporation
$542.52 from AbbVie, Inc.
$454.59 from Takeda Pharmaceuticals America, Inc.
$432.94 from Abbott Laboratories
$428.06 from Arbor Pharmaceuticals, Inc.
$359.23 from Valeritas, Inc.
$343.04 from Aytu BioScience, Inc
$295.28 from Pfizer Inc.
$283.90 from Tandem Diabetes Care, Inc.
$210.46 from Regeneron Healthcare Solutions, Inc.
Payments received by Dr. Moazzam Habib, MD were from the following categories:
$34,800.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!